This is a working overview of 非天然氨基酸, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-07-09. Anything still debated is marked as such rather than presented as settled.
The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.
Selectivity is the property most often attached to this peptide. Published animal and early human studies record increases in growth hormone release after administration, with adrenocorticotropic hormone and cortisol responses remaining small by comparison. Effects on appetite-related pathways also appear weaker than those reported for several earlier secretagogues. Reviews that compare members of the growth hormone secretagogue family cite these findings frequently, though the receptor-level explanation for the selectivity continues to be debated rather than settled.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.
Ipamorelin 是一种合成五肽，序列为 Aib-His-D-2-Nal-D-Phe-Lys-NH2，分子式 C38H49N9O5，游离碱分子量约 711.85 g/mol。它属于生长激素促分泌素（GHS）家族，作用靶点是胃饥饿素受体 GHS-R1a。该化合物由诺和诺德的研究团队在二十世纪九十年代末报道，设计目标是提高对生长激素释放的选择性。C 端酰胺化与 N 端 Aib 残基是两个用于抵抗肽酶降解的结构特征。
在 GHS 家族中，早期肽类如 GHRP-6 与 GHRP-2 会同时促进生长激素、皮质醇与催乳素的释放，并明显增加食欲。Ipamorelin 在动物与早期人体研究中表现出对生长激素释放的相对选择性，对上述其他激素的影响较小。这种差异通常归因于受体结合模式与下游信号偏向的不同，而完整的分子解释仍有待补充。需要区分的是，选择性是研究观察中的相对程度，并非绝对界限。
从用途定位看，ipamorelin 目前主要以研究用肽的身份被讨论，未见主要药品监管机构将其批准为治疗药物。市售材料通常标注仅供研究使用，不得用于人体或诊断程序。文献中它常与生长激素促分泌素、GHS-R1a 激动剂、胃饥饿素拟似物等表述并列出现。既有研究的样本量普遍偏小，因此对其效应强度与一致性的描述应保持谨慎。
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Pentapeptide with C-terminal amide |
| Average mass | Approximately 711.9 Da | Value derived from the formula |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water and aqueous acetonitrile | Dissolution aided by acidic diluents |
| Common synonyms | Ipamorelin; NNC 26-0161 | Code name used in early reports |
Human data remain limited and come mainly from small, short-term studies conducted decades ago. The peptide has not received approval as a medicine from major regulators, so current availability is largely as a research chemical. Reported effects on growth hormone pulsatility, appetite, and body composition should be read as preliminary, since few independent groups have replicated the original findings. Analytical characterization of research-grade material varies between suppliers, which complicates comparison across studies. Regulatory status also differs by country, and some jurisdictions classify it as a prescription-only or otherwise restricted item.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class. It acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. The compound was designed in the 1990s during a search for agents that release growth hormone with fewer off-target hormonal effects than earlier secretagogues. It appears in the research literature under several sequence-based names. Material supplied for laboratory work is normally a lyophilized solid, and it is not marketed as an approved therapeutic in major jurisdictions.
The molecule contains five residues, including alpha-aminoisobutyric acid, D-2-naphthylalanine, and D-phenylalanine, and it ends in a lysine amide. Non-natural and D-configured residues make the chain less susceptible to common peptidases, which helps explain its resistance to rapid breakdown. Its molecular formula is C38H49N9O5, corresponding to a free-base mass near 711.9 daltons. The C-terminal amide removes a negative charge and is a recurring feature in receptor-active peptides of this family. These structural choices are usually discussed as the basis for its selectivity profile.
Ipamorelin is a synthetic pentapeptide first described in the 1990s by researchers at Novo Nordisk during a program to develop selective growth hormone secretagogues. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues, alpha-aminoisobutyric acid and D-2-naphthylalanine. The C-terminus is amidated, and the material is supplied as a white lyophilized powder. The molecular formula is C38H49N9O5 and the monoisotopic mass is approximately 711.85 daltons. The short chain and modified residues give it greater resistance to enzymatic degradation than many larger peptide hormones.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor type 1a, the same G protein-coupled receptor that binds ghrelin. Receptor activation couples to Gq/11 signaling, raising intracellular calcium through inositol trisphosphate and diacylglycerol, which in turn promotes exocytosis of growth hormone from pituitary somatotroph cells. Ipamorelin binds this receptor with high affinity and shows weak activity at other secretagogue-related targets in vitro. Its action requires the intact receptor and is not reversed by growth hormone-releasing hormone antagonists.
Compared with earlier growth hormone secretagogues such as GHRP-6 and hexarelin, ipamorelin has been reported to produce less stimulation of adrenocorticotropic hormone, cortisol, and prolactin in animal and early human studies. This selectivity is usually attributed to differences in receptor subtype interactions and to the tissue distribution of the receptor. Effects on appetite appear weaker than those of ghrelin itself, although the supporting evidence base is small. Whether these differences produce a distinct clinical profile remains an open question, since controlled human trials are limited.
Storage recommendations for ipamorelin usually focus on temperature, moisture, and light. Lyophilized powder is typically held at or below minus twenty degrees Celsius in a desiccated container protected from light. Reconstituted solutions are often aliquoted and stored at minus eighty degrees Celsius to reduce repeated freeze-thaw cycles, which can promote aggregation or degradation. The optimal buffer and pH depend on the specific assay, and no single condition applies to every experimental context. Peptide stability should be assessed with time-point measurements rather than assumed from general handling rules.
In the scientific literature, ipamorelin appears mainly in preclinical studies, receptor binding assays, and reviews of growth hormone secretagogues. Authors often discuss its selectivity profile alongside limitations such as small sample sizes, short study durations, and differences between species. Some papers examine pharmacokinetics and clearance, but human data are limited and not sufficient to define general clinical effects. Regulatory discussion treats the compound as an investigational or research substance rather than an approved therapy in most jurisdictions. Open questions include oral bioavailability, long-term endocrine effects, and whether selectivity observed in animals persists in humans.
Research peptides such as ipamorelin are commonly supplied as lyophilized powder and characterized by analytical certificates. Reversed-phase high-performance liquid chromatography is used to estimate purity by ultraviolet absorbance, while mass spectrometry confirms molecular identity and detects sequence-related impurities. Counterion content, water content, and residual synthesis reagents can affect the reported mass balance. A certificate of analysis may list a purity percentage, but that number depends on the analytical method and the definition of impurity peaks. Independent verification is often recommended because research supply chains vary in quality control practices.
=== Malaysia === Secretary General of the Malaysian United Indigenous Party, Azmin Ali said that the operation "amounted to a unilateral and unlawful use of armed force under international law, in violation of Article 2(4) of the Charter of the United Nations" and called for the Malaysian government to "strengthen the Global South through the Non-Aligned Movement and enhance cross-regional cooperation, while lending support to international accountability mechanisms addressing violations of international law." The chairman of the People's Justice Party's International Affairs Bureau, Maszlee Malik, urged the US to halt all military actions against Venezuela, respect Venezuela's sovereignty and political freedom fully aligned with the Charter of the United Nations and demanded the international community to "preserve peace and prioritize diplomatic solutions through dialogue and multilateral forums".
=== Angiogenesis === Angiogenesis is an essential aspect of tumour development. In order for a tumour to grow and significantly increase in size, it must have a sufficient blood supply. If the tumour is unable to develop the blood supply it requires, cells within the tumour will begin to die and further growth will be halted. Angiogenic factors such as vascular endothelial growth factor (VEGF), stromal cell-derived factor 1 (SDF-1), fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF) are expressed by CAF to encourage the growth of new blood vessels. Some of these factors may also recruit cells that are vital to the angiogenic process, for instance SDF-1 attracts bone-marrow derived endothelial cells.
The Air Force School (TAFS), formerly known as Air Force Central School (AFCS), is a high school in Delhi, India. It was founded in 1955 by Chief of Air Staff Subroto Mukherjee. The school was established in temporary wartime barracks at Wellingdon Camp, on 18 July 1955 to educate children of the Indian Air Force personnel. In May 1967, the school moved to its Aravalli Campus location on the Aravalli ridge in Subroto Park, Delhi Cantonment. The school celebrated its Silver Jubilee in 1980, and dropped the word "Central" from its name. The school, and its sister schools, Air Force Bal Bharati School and the Air Force Golden Jubilee Institute are presently run by the Indian Air Force Educational and Cultural Society.
Sources: en.wikipedia.org
where F is the force applied to the ion, m is the mass of the particle, a is the acceleration, Q is the electric charge, E is the electric field, and v × B is the cross product of the ion's velocity and the magnetic flux density. This differential equation is the classic equation of motion for charged particles. Together with the particle's initial conditions, it completely determines the particle's motion in space and time in terms of m/Q. Thus mass spectrometers could be thought of as "mass-to-charge spectrometers". When presenting data in a mass spectrum, it is common to use the dimensionless m/z, which denotes the dimensionless quantity formed by dividing the mass number of the ion by its charge number. Combining the two previous equations yields:
Commission D1: Refrigerated Storage Commission D1 on Refrigerated Storage deals with the storage of all products which require temperature control, such as food and pharmaceuticals. Industrial, commercial and residential storage are also taken into account so that, in cooperation with Commission D2 Refrigerated Transport, the entire cold chain is treated, from raw materials to the final product at our home. Refrigeration plays an essential role in perishable products. While the estimated capacity of refrigerated warehouses was over 500 million cubic meters worldwide in 2014, in some countries, global food losses due to the lack of a cold chain are still very important and can reach as much as 20% of the global food supply. At the same time, in heavily industrialised countries, the use of commercial and domestic refrigerators accounts for up to 6% of global electricity consumption. As a result, the Commission faces important issues in order to promote widespread, energy-efficient, and environmentally friendly storage systems. New refrigerants, synergies to save or exchange energy with other systems, and new technologies are the main focus of its activity. One of the most important themes these days for this commission is energy efficiency.
Charcuterie – the branch of cooking devoted to prepared meat products, such as bacon, ham, sausage, terrines, galantines, pâtés, and confit, primarily from pork. Charcuterie is part of the garde manger chef's repertoire. Originally intended as a way to preserve meat before the advent of refrigeration, they are prepared today for their flavors derived from the preservation processes. Charque – a form of jerky common in South America made from dried and salted meat, originally llama where this animal roamed, but nowadays mostly beef. Chinese sausage – a generic term referring to the many different types of sausages originating in China. Chipped beef – thinly sliced or pressed salted and dried beef. Some varieties are smoked to add flavor. Chorizo – can be a fresh sausage, in which case it must be cooked before eating. In Europe, it is more frequently a fermented, salt-cured, smoked sausage Cold cut – precooked or cured meat, including dried sausages. Country ham – a variety of cured ham that is typically very salty. Country hams are salt-cured (and occasionally nitrite- and nitrate-cured) for one to three months. Culatello – a refined variety of prosciutto, made from heavier pigs, cut to a fraction of the normal prosciutto and aged, and may be cured with wine, with culatello di Zibello having PDO status.
Australia: Electronic Travel Authority (ETA) eVisitor programme East African Community: From February 2014, Kenya, Rwanda and Uganda issue an East African Tourist Visa. Hong Kong: Mainland Travel Permit for Taiwan Residents India: India permits nationals of most jurisdictions to clear border controls using an e-visa. Kenya: From 1 January 2021, Kenya solely issues e-visas, and physical visas are no longer available. New Zealand: Electronic Travel Authority (NZeTA) North America: Canadian ETA, US Electronic System for Travel Authorisation Pakistan: Pakistani ETA. South Korea: eligible visa-free visitors must obtain Korea Electronic Travel Authorization (K-ETA). Sri Lanka: Sri Lankan ETA Qatar: ETA needed for up to 30 days. United Kingdom: Electronic Visa Waiver, or EVW The Nationality and Borders Bill, before the parliament in Spring 2022, includes a proposal to introduce the Electronic Travel Authorisation system for all non-UK and Irish citizens.
Sources: en.wikipedia.org
The request for a sequel to The Hobbit prompted Tolkien to begin what ultimately developed into his magnum opus: the epic high-fantasy novel The Lord of the Rings. Written in stages and heavily expanded from its original scope, the novel was published in three volumes between 1954 and 1955. Tolkien spent more than ten years writing the primary narrative and appendices for The Lord of the Rings, during which time he received the constant support of the Inklings, in particular his closest friend C. S. Lewis, the author of The Chronicles of Narnia. Both The Hobbit and The Lord of the Rings are set against the background of The Silmarillion, but in a time long after it. Tolkien at first intended The Lord of the Rings to be a children's tale in the style of The Hobbit, but it quickly grew darker and more serious in the writing. Though a direct sequel to The Hobbit, it addressed an older audience, drawing on the immense backstory of Beleriand that Tolkien had constructed in previous years, which eventually saw posthumous publication in The Silmarillion and other volumes. Tolkien strongly influenced the fantasy genre that grew up after the book's success. The Lord of the Rings became immensely popular in the 1960s and has remained so ever since, ranking as one of the most popular works of fiction of the 20th century, judged by both sales and reader surveys. In the 2003 "Big Read" survey conducted by the BBC, The Lord of the Rings was found to be the UK's "Best-loved Novel".
Only some of the Ruthenian szlachta of the Chernigov region, who had their origins in the Moscow state, saved their lands from division among Cossacks and became part of the Cossack szlachta. After this, the Ruthenian szlachta refrained from plans to have a Moscow Tsar as king of the Commonwealth, its own Michał Korybut Wiśniowiecki later becoming king. The last, ultimately unsuccessful, attempt to rebuild the Polish–Cossack alliance and create a Polish–Lithuanian–Ruthenian Commonwealth was the 1658 Treaty of Hadiach. The treaty was approved by the Polish king and the Sejm, and by some of the Cossack starshyna, including hetman Ivan Vyhovsky. The treaty failed, however, because the starshyna were divided on the issue, and it had even less support among rank-and-file Cossacks.
Glutathione S-transferase theta-2 is an enzyme that in humans is encoded by the GSTT2 gene. Glutathione S-transferase (GSTs) theta 2 (GSTT2) is a member of a superfamily of proteins that catalyze the conjugation of reduced glutathione to a variety of electrophilic and hydrophobic compounds. Human GSTs can be divided into five main classes: Alpha, Mu, Pi, Theta, and Zeta. The theta class members GSTT1 and GSTT2 share 55% amino acid sequence identity and both are thought to have an important role in human carcinogenesis. The theta genes have a similar structure, being composed of five exons with identical exon/intron boundaries.
Sources: en.wikipedia.org
It is a synthetic five-amino-acid peptide that acts as a growth hormone secretagogue. Three of its residues are non-standard amino acids, and the chain ends in an amide rather than a free acid. The molecule is small enough that it can be characterised by routine peptide analytical techniques.
It has not received marketing approval as a medicine in the United States or the European Union. Supplied material is generally described and handled as a research chemical. Regulatory treatment varies by jurisdiction, and some countries restrict growth hormone secretagogues under sports or medicines legislation.
Earlier secretagogues were associated with broader hormonal responses, including measurable changes in cortisol and prolactin. Reports on this peptide describe a narrower profile in which growth hormone release is the most prominent effect. The observation is influential because it shapes how the compound is compared with other members of the same receptor family.
两者都是 GHS-R1a 激动剂，但 ipamorelin 在研究中显示出更高的生长激素释放选择性。早期资料显示它对皮质醇、催乳素与食欲的刺激弱于 GHRP-6。这些差异是相对程度，而非绝对区分。